Premarin (Conjugated Estrogens) - Adverse Event Reports - Hospitalization - Breast Cancer

Adverse event in 43 year old female receiving Premarin (Conjugated Estrogens)

Reported by a physician from United States on 2007-10-30

Patient: 43 year old female

Adverse reactions / side effects: Breast Cancer, Type 2 Diabetes Mellitus, Hypertension

Adverse event resulted in: hospitalization

Suspect drug(s):
Premarin (Conjugated Estrogens)

Adverse event in 60 year old female receiving Premarin (Conjugated Estrogens)

Reported by a individual with unspecified qualification from United States on 2007-10-30

Patient: 60 year old female, weighing 76.7 kg (168.8 pounds)

Adverse reactions / side effects: Breast Cancer

Adverse event resulted in: hospitalization

Suspect drug(s):
Premarin (Conjugated Estrogens)

Adverse event in female receiving Premarin (Conjugated Estrogens)

Reported by a individual with unspecified qualification from United States on 2007-10-30

Patient: female

Adverse reactions / side effects: Breast Cancer

Adverse event resulted in: hospitalization

Suspect drug(s):
Premarin (Conjugated Estrogens)

Adverse event in 60 year old female receiving Premarin (Conjugated Estrogens)

Reported by a individual with unspecified qualification from United States on 2007-10-30

Patient: 60 year old female, weighing 76.7 kg (168.8 pounds)

Adverse reactions / side effects: Breast Cancer

Adverse event resulted in: hospitalization

Suspect drug(s):
Premarin (Conjugated Estrogens)

Adverse event in 65 year old female receiving Premarin (Conjugated Estrogens)

Reported by a individual with unspecified qualification from United States on 2007-10-30

Patient: 65 year old female

Adverse reactions / side effects: Breast Cancer

Adverse event resulted in: hospitalization

Suspect drug(s):
Premarin

Provera

Adverse event in 54 year old female receiving Premarin (Conjugated Estrogens)

Reported by a individual with unspecified qualification from United States on 2007-10-30

Patient: 54 year old female, weighing 74.9 kg (164.8 pounds)

Adverse reactions / side effects: Breast Cancer

Adverse event resulted in: hospitalization

Suspect drug(s):
Premarin

Provera

Adverse event in 65 year old female receiving Premarin (Conjugated Estrogens)

Reported by a individual with unspecified qualification from United States on 2007-10-30

Patient: 65 year old female

Adverse reactions / side effects: Breast Cancer

Adverse event resulted in: hospitalization

Suspect drug(s):
Premarin

Provera

Adverse event in 58 year old female receiving Premarin (Conjugated Estrogens)

Reported by a physician from United States on 2007-10-30

Patient: 58 year old female, weighing 132.2 kg (290.8 pounds)

Adverse reactions / side effects: Breast Cancer

Adverse event resulted in: hospitalization

Suspect drug(s):
Premarin (Conjugated Estrogens)

Other drugs received by patient: Synthroid; Multivitamins, Plain (Multivitamins, Plain); Aspirin; Calcium (Calcium); Glucophage; Neurontin; Allegra-D (Fexofenadine Hydrochloride / Pseudoephedrine Hydrochloride); Advair Diskus 100 / 50; Cymbalta

Adverse event in 54 year old female receiving Premarin (Conjugated Estrogens)

Reported by a individual with unspecified qualification from United States on 2007-10-30

Patient: 54 year old female, weighing 74.9 kg (164.8 pounds)

Adverse reactions / side effects: Breast Cancer

Adverse event resulted in: hospitalization

Suspect drug(s):
Premarin

Provera

Adverse event in 58 year old female receiving Premarin (Conjugated Estrogens)

Reported by a individual with unspecified qualification from United States on 2007-10-24

Patient: 58 year old female

Adverse reactions / side effects: Breast Reconstruction, Weight Decreased, Biopsy Breast Abnormal, Pneumonia Aspiration, Diverticulitis, Chronic Obstructive Pulmonary Disease, Chemotherapy, Colonic Polyp, Cough, Breast Cancer, Wound Dehiscence, Hyperglycaemia, Colonoscopy, Radiotherapy, Cataract Operation, Vision Blurred, Necrosis Ischaemic, Haemorrhage, Rectal Haemorrhage, Pain, Neuropathy Peripheral, Fibromyalgia, Pulmonary Congestion, Breast Cosmetic Surgery, Wound Drainage, Type 2 Diabetes Mellitus, Dyspnoea, Skin Graft, Haemorrhoids, Intraocular Lens Implant, Radical Mastectomy, Diarrhoea, Diabetic Retinopathy, Wound Debridement, Hypertension

Adverse event resulted in: hospitalization

Suspect drug(s):
Premarin
    Indication: Hormone Replacement Therapy
    End date: 1997-01-01

Vivelle
    Indication: Hormone Replacement Therapy
    End date: 2001-01-01

Adverse event in 72 year old female receiving Premarin (Conjugated Estrogens)

Reported by a individual with unspecified qualification from United States on 2007-07-17

Patient: 72 year old female, weighing 93.0 kg (204.5 pounds)

Adverse reactions / side effects: Diabetes Mellitus, Pyrexia, Cerebrovascular Disorder, Chronic Obstructive Pulmonary Disease, Macular Degeneration, Cerebral Ischaemia, Colonic Polyp, Glomerulonephritis, Breast Microcalcification, Lymphadenectomy, Breast Cancer, Coronary Angioplasty, Radiotherapy, Breast Mass, Coronary Artery Disease, Tremor, Cholelithiasis, Diverticulum, Arachnoid Cyst, Nervous System Disorder, Cholecystectomy, Adenoma Benign, Spinal Column Stenosis, Refractory Anaemia, Myelodysplastic Syndrome, Dialysis, Cholecystitis, Depression, Acute Myocardial Infarction, Endometrial Disorder, Macrocytosis, Gouty Arthritis, Peripheral Vascular Disorder, Malignant Breast Lump Removal, Cerebrovascular Accident, Renal Failure Chronic, Vascular Graft, Hyperlipidaemia, Anxiety, Osteoarthritis, Peritoneal Dialysis, Hypothyroidism, Hypertension, Infection

Adverse event resulted in: hospitalization

Suspect drug(s):
Cycrin
    Dosage: 5 mg, unk
    Administration route: Oral
    Indication: Menopause
    Start date: 1999-01-01
    End date: 1999-01-01

Estraderm
    Dosage: 0.5 mg, unk
    Indication: Menopause
    Start date: 1991-01-01
    End date: 1996-01-01

MPA
    Dosage: 5 mg, unk
    Administration route: Oral
    Indication: Menopause
    Start date: 1999-01-01
    End date: 2000-01-01

Premarin
    Administration route: Oral
    Indication: Menopause
    Start date: 1999-01-01
    End date: 2001-01-01

Provera
    Dosage: 2.5 mg, unk
    Administration route: Oral
    Indication: Menopause
    Start date: 1991-01-01
    End date: 1999-01-01

Other drugs received by patient: Celexa; Zestril; Metoprolol Succinate; Lortab; Lipitor; Allopurinol; Synthroid; Ranitidine; Nitroglycerin; Nortriptyline HCL; Norvasc; Cardizem; Capoten; Mevacor; Voltaren; Zaroxolyn

Adverse event in 66 year old female receiving Premarin (Conjugated Estrogens)

Reported by a individual with unspecified qualification from United States on 2007-07-10

Patient: 66 year old female, weighing 56.7 kg (124.7 pounds)

Adverse reactions / side effects: Pyrexia, Macrognathia, Vaginal Disorder, Smear Cervix Abnormal, Mammogram Abnormal, Colonic Polyp, Coeliac Disease, Irritable Bowel Syndrome, Bone Density Decreased, Temperature Intolerance, Cough, Breast Cancer, Pneumonia, Vaginal Discharge, Breast Mass, Cataract Operation, Meniere's Disease, Temporomandibular Joint Syndrome, Vision Blurred, Platelet Count Decreased, Gastric Polyps, Lactose Intolerance, Restless Legs Syndrome, Thrombocythaemia, Blood Thyroid Stimulating Hormone Increased, Hepatitis, Hypokalaemia, Pleural Effusion, Genital Disorder Female, Blood Cholesterol Increased, Depression, Injury, Gastrooesophageal Reflux Disease, Loss of Libido, Cataract, Breast Disorder, Hepatic Enzyme Increased, Anxiety, Mucosal Inflammation, Oral Pain, Epigastric Discomfort, Mastectomy, Hypothyroidism, Hypertension

Adverse event resulted in: hospitalization

Suspect drug(s):
Aygestin

Combipatch
    Indication: Menopause
    Start date: 1991-01-01

Combipatch
    Dosage: 0.25 mg, unk
    Start date: 2000-01-01
    End date: 2000-01-01

Estraderm
    Dosage: 0.05 mg, unk
    Indication: Menopause
    Start date: 1994-12-01
    End date: 2002-01-01

Estratest

Estrogenic Substance

Ogen
    Indication: Menopause

Oragest
    Indication: Menopause

Premarin

Premarin
    Indication: Menopause
    Start date: 1990-01-01
    End date: 1992-01-01

Premarin
    Start date: 1990-01-01
    End date: 1992-01-01

Premarin
    Start date: 1990-01-01
    End date: 1992-01-01

Prempro

Provera
    Dosage: 5 mg for 14 days every other month
    Indication: Menopause
    Start date: 1995-08-01
    End date: 1995-09-01

Vivelle
    Dosage: 0.05 mg, unk
    Indication: Menopause

Adverse event in female receiving Premarin (Conjugated Estrogens)

Reported by a lawyer from United States on 2007-07-03

Patient: female, weighing 61.3 kg (134.8 pounds)

Adverse reactions / side effects: Breast Cancer

Adverse event resulted in: hospitalization

Suspect drug(s):
Premarin

Provera
    Dosage: unspecified
    Indication: Hormone Replacement Therapy
    Start date: 1993-04-01
    End date: 2001-10-01

Adverse event in 62 year old female receiving Premarin (Conjugated Estrogens)

Reported by a individual with unspecified qualification from United States on 2007-07-02

Patient: 62 year old female, weighing 99.8 kg (219.5 pounds)

Adverse reactions / side effects: Polyp Colorectal, Mammogram Abnormal, Fibrocystic Breast Disease, Intervertebral Disc Disorder, Postmenopausal Haemorrhage, Breast Microcalcification, Blood Cholesterol Increased, Benign Breast Neoplasm, Breast Hyperplasia, Breast Cancer, Tonsillectomy, Abscess Drainage, Mastitis, Radiotherapy, Malignant Breast Lump Removal, Appendicitis, Anal Fissure, Haematochezia, Hysterectomy, Uterine Dilation and Curettage, Colonoscopy Abnormal

Adverse event resulted in: hospitalization

Suspect drug(s):
Cycrin
    Start date: 1999-01-01

Estrace
    Dosage: unk, qhs
    Start date: 1999-01-01

Estraderm
    Start date: 1989-01-01

Estratest
    Start date: 1990-01-01
    End date: 1999-01-01

Premarin
    Dosage: 0.625 unk, unk
    Administration route: Oral
    Start date: 1989-01-01

Prempro
    Indication: Menopause
    Start date: 1999-04-01
    End date: 2002-04-01

Provera
    Dosage: 10 mg, unk
    Start date: 1989-01-01

Other drugs received by patient: Steroids NOS; Oxygen Therapy; Lotrel; Cardizem

Adverse event in female receiving Premarin (Conjugated Estrogens)

Reported by a physician from United States on 2007-06-14

Patient: female, weighing 72.1 kg (158.6 pounds)

Adverse reactions / side effects: Breast Cancer

Adverse event resulted in: hospitalization

Suspect drug(s):
Activella
    Dosage: unknown
    Administration route: Oral
    Indication: Menopausal Symptoms
    Start date: 1999-08-01
    End date: 2002-10-01

MPA
    Dosage: unknown
    Indication: Menopausal Symptoms
    Start date: 1987-01-01
    End date: 2001-01-01

Premarin
    Dosage: .625 mg, unk
    Indication: Menopausal Symptoms
    Start date: 1987-01-01
    End date: 1998-01-01

Prempro
    Dosage: .625 mg / 2.5mg, unk
    Indication: Menopausal Symptoms
    Start date: 1998-04-01
    End date: 1998-11-01

Prempro
    Dosage: .625 mg /2.5 mg
    Start date: 1999-07-01
    End date: 1999-11-01

Prempro
    Dosage: .625 mg/ 0.5mg
    Start date: 1998-11-01
    End date: 1999-07-01

Prempro
    Dosage: .625 mg/.05 mg
    Start date: 1999-11-01
    End date: 2001-04-01

Provera
    Dosage: 10 mg, unk
    Indication: Menopausal Symptoms
    Start date: 1994-04-01
    End date: 1998-08-01

Provera
    Dosage: 2.5 mg, unk
    Start date: 1998-08-01
    End date: 1998-11-01

Other drugs received by patient: Naprosyn; Celebrex; Iron; Glucosamine; Vitamin E / 00110501 /; Elavil / 00002202 /; Fosamax

Adverse event in female receiving Premarin (Conjugated Estrogens)

Reported by a lawyer from United States on 2007-06-07

Patient: female, weighing 81.7 kg (179.8 pounds)

Adverse reactions / side effects: Breast Cancer, Labile Hypertension, Condition Aggravated, Cardiac Disorder

Adverse event resulted in: hospitalization

Suspect drug(s):
Premarin
    Dosage: 0.625mg daily days 1-30
    Administration route: Oral
    Indication: Menopause
    Start date: 1991-01-01
    End date: 1996-01-01

Prempro
    Dosage: 0.625mg/2.5mg daily
    Administration route: Oral
    Indication: Hormone Replacement Therapy
    Start date: 1996-01-01
    End date: 2001-09-01

Provera
    Dosage: 5mg daily days 1-12
    Administration route: Oral
    Indication: Menopause
    Start date: 1991-01-01
    End date: 1996-01-01

Other drugs received by patient: Acetylsalicylic Acid SRT; Xanax; Proventil-HFA; Prilosec; Demadex; Zoloft

Adverse event in 56 year old female receiving Premarin (Conjugated Estrogens)

Reported by a individual with unspecified qualification from United States on 2007-05-22

Patient: 56 year old female, weighing 65.8 kg (144.7 pounds)

Adverse reactions / side effects: Breast Reconstruction, Breast Cancer, Cellulitis, Skin Exfoliation, Radiotherapy, Immunodeficiency, Breast Mass, Erythema, Skin Discolouration, Alopecia, Modified Radical Mastectomy, Tenderness, Depression, Blister, Scar

Adverse event resulted in: hospitalization

Suspect drug(s):
Combipatch
    Dosage: .05/.14
    Indication: Menopause
    Start date: 1999-02-04
    End date: 1999-08-01

Medroxyprogesterone
    Dosage: 2.5 mg, qd
    Administration route: Oral
    Indication: Menopause
    Start date: 1999-09-23
    End date: 2002-04-19

Premarin
    Dosage: 0.625 mg, qd
    Administration route: Oral
    Indication: Menopause
    Start date: 1999-09-23
    End date: 1999-10-01

Prempro
    Dosage: 2.5 mg, unk
    Administration route: Oral
    Indication: Menopause
    Start date: 1997-08-15
    End date: 1999-01-01

Provera
    Dosage: 2.5 mg, unk
    Administration route: Oral
    Indication: Menopause
    Start date: 1997-08-15
    End date: 1997-12-01

Other drugs received by patient: Wellbutrin; Atenolol; Ranitidine; Zoloft; Nitroglycerin

Adverse event in female receiving Premarin (Conjugated Estrogens)

Reported by a consumer/non-health professional from United States on 2007-05-16

Patient: female, weighing 61.3 kg (134.8 pounds)

Adverse reactions / side effects: Blood Pressure Increased, Breast Cancer, Angina Unstable, Aortic Valve Sclerosis, Breast Cancer Female, Oestrogen Receptor Assay Positive, Myocardial Infarction

Adverse event resulted in: hospitalization

Suspect drug(s):
Premarin

Prempro

Provera

Adverse event in female receiving Premarin (Conjugated Estrogens)

Reported by a lawyer from United States on 2007-05-10

Patient: female, weighing 81.7 kg (179.8 pounds)

Adverse reactions / side effects: Breast Cancer, Labile Hypertension, Condition Aggravated, Cardiac Disorder

Adverse event resulted in: hospitalization

Suspect drug(s):
Premarin
    Dosage: 0.625mg daily days 1-30
    Administration route: Oral
    Indication: Menopause
    Start date: 1991-01-01
    End date: 1996-01-01

Prempro
    Dosage: 0.625mg/2.5mg daily
    Administration route: Oral
    Indication: Hormone Replacement Therapy
    Start date: 1996-01-01
    End date: 2001-09-01

Provera
    Dosage: 5mg daily days 1-12
    Administration route: Oral
    Indication: Menopause
    Start date: 1991-01-01
    End date: 1996-01-01

Other drugs received by patient: Acetylsalicylic Acid SRT; Xanax; Proventil-HFA; Prilosec; Demadex; Zoloft

Adverse event in 59 year old female receiving Premarin (Conjugated Estrogens)

Reported by a physician from United States on 2007-05-10

Patient: 59 year old female

Adverse reactions / side effects: Ventricular Extrasystoles, Breast Cancer, Pseudomonas Infection, Aortic Valve Sclerosis, Blood Thyroid Stimulating Hormone Abnormal, Osteopenia, Breast Cellulitis, Arrhythmia, Anxiety, Palpitations, Breast Tenderness, Postmenopausal Haemorrhage, Sinus Tachycardia, Hyperthyroidism, Aortic Valve Incompetence, Excessive Granulation Tissue

Adverse event resulted in: hospitalization

Suspect drug(s):
Estraderm
    Dosage: 0.1mg patch/2x week
    Indication: Menopause
    Start date: 1996-01-01
    End date: 2002-01-24

Premarin
    Dosage: 1.25 mg, bid
    Indication: Menopause
    Start date: 2000-04-01
    End date: 2000-04-01

Provera
    Dosage: 2.5 mg, qd
    Administration route: Oral
    Indication: Menopause
    Start date: 1996-01-01
    End date: 2002-01-24

Vivelle
    Dosage: 0.05 mg patch/2xweek
    Indication: Menopause
    Start date: 1996-01-01
    End date: 1996-01-01

Other drugs received by patient: Atenolol

Adverse event in female receiving Premarin (Conjugated Estrogens)

Reported by a consumer/non-health professional from United States on 2007-04-26

Patient: female, weighing 86.3 kg (189.8 pounds)

Adverse reactions / side effects: Breast Cancer, Haemorrhagic Stroke

Adverse event resulted in: hospitalization

Suspect drug(s):
Premarin

Prempro

Provera

Adverse event in 57 year old female receiving Premarin (Conjugated Estrogens)

Reported by a physician from United States on 2007-04-23

Patient: 57 year old female, weighing 59.0 kg (129.7 pounds)

Adverse reactions / side effects: Uterine Polyp, Pain, Endometrial Hypertrophy, Fibrocystic Breast Disease, Breast Cyst, Reflux Oesophagitis, Dyspepsia, Chest Pain, Postmenopausal Haemorrhage, Breast Hyperplasia, Breast Cancer, Haemorrhoids, Breast Mass, Radiotherapy, Anxiety, Lung Disorder, Uterine Dilation and Curettage, Mastectomy, Gastrooesophagitis

Adverse event resulted in: hospitalization

Suspect drug(s):
Combipatch
    Administration route: Topical
    Indication: Hormone Replacement Therapy
    Start date: 1992-01-01
    End date: 1995-01-01

Estraderm
    Administration route: Topical
    Indication: Hormone Replacement Therapy

Premarin
    Dosage: 0.625/0.3 mg
    Start date: 1986-01-01
    End date: 1992-01-01

Prempro
    Dosage: 0.625/2.5mg
    Administration route: Oral
    Indication: Hormone Replacement Therapy
    Start date: 1995-01-01
    End date: 1999-01-01

Provera
    Start date: 1986-01-01
    End date: 1992-01-01

Other drugs received by patient: Synthroid; Zoloft; Ativan; Tamoxifen Citrate

Adverse event in 59 year old female receiving Premarin (Conjugated Estrogens)

Reported by a individual with unspecified qualification from United States on 2007-04-20

Patient: 59 year old female, weighing 59.0 kg (129.7 pounds)

Adverse reactions / side effects: Abdominal Pain, Pain, Rectal Haemorrhage, Endometrial Hypertrophy, Colonic Polyp, Breast Cyst, Fibrocystic Breast Disease, Haemangioma of Liver, Depression Suicidal, Neck Pain, Uterine Leiomyoma, Breast Microcalcification, Breast Cosmetic Surgery, Postmenopausal Haemorrhage, Injury, Exostosis, Radiculopathy, Intervertebral Disc Protrusion, Breast Cancer, Dyspareunia, Spinal Cord Compression, Haemorrhoids, Breast Mass, Radiotherapy, Modified Radical Mastectomy, Suicide Attempt, Spinal Osteoarthritis

Adverse event resulted in: hospitalization

Suspect drug(s):
Estraderm
    Dosage: 0.05 mg twice weekly
    Indication: Hormone Replacement Therapy
    Start date: 1993-08-20
    End date: 1997-03-04

Estratest
    Dosage: unk, qhs tab
    Administration route: Oral
    Indication: Menopause
    Start date: 1997-04-16
    End date: 1997-05-01

MPA
    Dosage: unk, qd one tab
    Administration route: Oral
    Indication: Menopause
    Start date: 1993-08-09
    End date: 1997-05-01

Premarin
    Dosage: 0.625 mg, unk
    Administration route: Oral
    Indication: Menopause
    Start date: 1993-08-09
    End date: 1993-08-20

Premarin
    Dosage: 0.6 unk, unk
    Administration route: Topical
    Indication: Vulvovaginal Dryness
    Start date: 2000-04-07
    End date: 2003-03-04

Premphase 14 / 14
    Dosage: .625/5 mg/day
    Administration route: Oral
    Indication: Menopause
    Start date: 1996-04-12
    End date: 1999-03-10

Prempro
    Dosage: 0.625 mg, unk
    Administration route: Oral
    Indication: Menopause
    Start date: 1999-03-10
    End date: 1999-07-09

Provera
    Dosage: unk, qd, one tab
    Administration route: Oral
    Indication: Menopause
    Start date: 1993-08-09
    End date: 1997-05-01

Other drugs received by patient: Prozac; Valium; Evista; Contraceptives NOS

Adverse event in 50 year old female receiving Premarin (Conjugated Estrogens)

Reported by a individual with unspecified qualification from United States on 2007-04-16

Patient: 50 year old female, weighing 74.8 kg (164.6 pounds)

Adverse reactions / side effects: Chronic Fatigue Syndrome, Sciatica, Headache, Loss of Consciousness, Vascular Calcification, Hot Flush, Palpitations, Breast Microcalcification, Arteriosclerosis, Muscle Spasms, Breast Pain, Breast Cancer, Back Pain, Pain in Extremity, FAT Necrosis, Osteopenia, Radiculitis Brachial, Pain, Fall, Suicidal Ideation, Fibromyalgia, Intervertebral Disc Disorder, Musculoskeletal Stiffness, Dizziness, Depression, Gastrooesophageal Reflux Disease, Migraine, Dyspnoea, Cervicobrachial Syndrome, Malignant Breast Lump Removal, Arthralgia, Epigastric Discomfort, Spinal Osteoarthritis, Hypertension, Asthenia, Arthritis

Adverse event resulted in: hospitalization

Suspect drug(s):
Estraderm
    Dosage: 0.05mg unk
    Administration route: Topical
    Indication: Menopause
    Start date: 1993-07-20

Estrogens Conjugated
    Dosage: 0.625mg
    Administration route: Oral
    Start date: 1995-08-07
    End date: 1995-08-11

Premarin
    Dosage: 0.3mg qd
    Indication: Menopause

Prempro
    Dosage: 0.625mg/2.5mg
    Start date: 1998-06-29
    End date: 2000-01-01

Prempro
    Dosage: ez dial
    Start date: 2000-01-03
    End date: 2000-04-18

Prempro
    Dosage: .625mg/2.5mg
    Start date: 2000-04-01
    End date: 2001-01-01

Prempro
    Dosage: .625mg/5mg
    Start date: 2001-02-01
    End date: 2002-04-12

Provera
    Dosage: 10mg
    Indication: Menopause

Other drugs received by patient: Cartia / USA /; Buspar; Buspar; Nortriptyline HCL; Prozac; Cardizem; Promethazine; Cozaar; Ritalin; Zoloft; Valium; Midrin; Synthroid; Norflex; Desyrel; Klonopin; Compazine; Tylenol W / Codeine NO. 3; Indocin; Lopressor; Pamelor; Protonix; Percocet; Skelaxin; Tamoxifen; Voltaren; Soma; Fioricet; Celebrex; Darvocet-N 100; Fioricet W / Codeine; Levothyroxine Sodium; Adalat - Slow Release; Vicodin

Adverse event in 58 year old female receiving Premarin (Conjugated Estrogens)

Reported by a individual with unspecified qualification from United States on 2007-04-16

Patient: 58 year old female, weighing 72.6 kg (159.6 pounds)

Adverse reactions / side effects: Atrial Tachycardia, Wheelchair User, Urinary Incontinence, Corneal Disorder, Tricuspid Valve Incompetence, Seroma, Hot Flush, Upper Respiratory Tract Infection, Balance Disorder, Breast Microcalcification, Nodule, Lymphadenectomy, Gallbladder Disorder, Multiple Sclerosis, Muscle Spasms, Breast Cancer, Gastrointestinal Motility Disorder, Dysphagia, Pain in Extremity, Supraventricular Tachycardia, Faecal Incontinence, Breast Mass, Radiotherapy, Osteopenia, Cholelithiasis, Epicondylitis, Spleen Disorder, Cholecystectomy, Muscle Spasticity, Hepatitis, Fall, Myalgia, Diplopia, Speech Disorder, Fatigue, Chest Pain, Blood Cholesterol Increased, Musculoskeletal Stiffness, Cholecystitis, Depression, Gastrooesophageal Reflux Disease, Iridectomy, Neurogenic Bladder, Muscular Weakness, Malignant Breast Lump Removal, Angle Closure Glaucoma, Hepatic Enzyme Increased, Osteoarthritis, Mitral Valve Incompetence, Gait Disturbance

Adverse event resulted in: hospitalization

Suspect drug(s):
Estraderm
    Dosage: 0.1mg
    Administration route: Topical
    Indication: Hormone Replacement Therapy
    Start date: 1992-01-01
    End date: 1997-01-01

MPA
    Indication: Hormone Replacement Therapy
    Start date: 1984-01-01
    End date: 1997-01-01

Premarin

Prempro
    Dosage: .625mg/2.5mg
    Start date: 1998-01-26
    End date: 1998-10-21

Prempro
    Dosage: .625mg/5mg
    Start date: 1998-11-16
    End date: 2000-10-19

Provera
    Dosage: 10mg unk
    Start date: 1984-01-01
    End date: 1997-01-01

Other drugs received by patient: Prozac; Tamoxifen Citrate; Hydrocodone